Terms: = Leukemia AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Prognosis
18 results:
1. Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.
Gaumond SI; Abdin R; Costoya J; Schally AV; Jimenez JJ
Oncotarget; 2024 Apr; 15():248-254. PubMed ID: 38588464
[TBL] [Abstract] [Full Text] [Related]
2. Novel identification of t(14;18)(q32;q21)/IGH::MALT1 in chronic lymphocytic leukaemia.
Kumar J; Ewalt MD; Zhang Y; Yao J; Thompson MC; Dogan A
Br J Haematol; 2024 Feb; 204(2):561-565. PubMed ID: 38031233
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical characteristics of 11 patients with chronic lymphocytic leukemia with t (14;19) (q32;q13)].
Cui CH; Chang YN; Zhou J; Li CW; Wang HJ; Sun Q; Jia YJ; Li QH; Wang TY; Qiu LG; Yi SH
Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):418-423. PubMed ID: 37550193
[No Abstract] [Full Text] [Related]
4. [Clinical analysis of 20 cases of small B lymphocyte proliferative disease with t (14;19) (q32;q13)].
Yang H; Guo R; Shi Y; Qiao C; Wu YJ; Fan L; Xu W; Miao KR; Li JY; Qiu HR
Zhonghua Xue Ye Xue Za Zhi; 2022 Aug; 43(8):674-679. PubMed ID: 36709153
[No Abstract] [Full Text] [Related]
5. BCL‑3 promotes cyclooxygenase‑2/prostaglandin E2 signalling in colorectal cancer.
Collard TJ; Fallatah HM; Greenhough A; Paraskeva C; Williams AC
Int J Oncol; 2020 May; 56(5):1304-1313. PubMed ID: 32319612
[TBL] [Abstract] [Full Text] [Related]
6. The prognostic effect of smoking status on intensively treated acute myeloid leukaemia - A Danish nationwide cohort study.
Kristensen D; Nielsen LB; Roug AS; Kristensen TC; El-Galaly TC; Nørgaard JM; Marcher CW; Schöllkopf C; Theilgaard-Mönch K; Severinsen MT
Br J Haematol; 2020 Jul; 190(2):236-243. PubMed ID: 32316076
[TBL] [Abstract] [Full Text] [Related]
7. The role of B-Cell Lymphoma-3 (BCL-3) in enabling the hallmarks of cancer: implications for the treatment of colorectal carcinogenesis.
Legge DN; Chambers AC; Parker CT; Timms P; Collard TJ; Williams AC
Carcinogenesis; 2020 May; 41(3):249-256. PubMed ID: 31930327
[TBL] [Abstract] [Full Text] [Related]
8. Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantation.
Sun YQ; Wang Y; Zhang XH; Xu LP; Liu KY; Yan CH; Liu ZY; Huang XJ
Ann Hematol; 2019 Aug; 98(8):1877-1883. PubMed ID: 31144019
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic and predictive value of a microRNA signature in adults with T-cell lymphoblastic lymphoma.
Tian XP; Huang WJ; Huang HQ; Liu YH; Wang L; Zhang X; Lin TY; Rao HL; Li M; Liu F; Zhang F; Zhong LY; Liang L; Lan XL; Li J; Liao B; Li ZH; Tang QL; Liang Q; Shao CK; Zhai QL; Cheng RF; Sun Q; Ru K; Gu X; Lin XN; Yi K; Shuang YR; Chen XD; Dong W; Sang W; Sun C; Liu H; Zhu ZG; Rao J; Guo QN; Zhou Y; Meng XL; Zhu Y; Hu CL; Jiang YR; Zhang Y; Gao HY; He WJ; Xia ZJ; Wu CL; Zhang MY; Wang HY; Xie D; Cai QQ
Leukemia; 2019 Oct; 33(10):2454-2465. PubMed ID: 30953029
[TBL] [Abstract] [Full Text] [Related]
10. bcl3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid leukemia of FAB Subtype M2.
Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
[TBL] [Abstract] [Full Text] [Related]
11. Molecular Markers and prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis.
Lee YC; Hsieh CC; Lee YL; Li CY
Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):558-568. PubMed ID: 29970342
[TBL] [Abstract] [Full Text] [Related]
12. Night shift work and chronic lymphocytic leukemia in the MCC-Spain case-control study.
Costas L; Benavente Y; Olmedo-Requena R; Casabonne D; Robles C; Gonzalez-Barca EM; de la Banda E; Alonso E; Aymerich M; Tardón A; Marcos-Gragera R; Gimeno-Vázquez E; Gómez-Acebo I; Papantoniou K; Castaño-Vinyals G; Aragonés N; Pollán M; Kogevinas M; de Sanjosé S
Int J Cancer; 2016 Nov; 139(9):1994-2000. PubMed ID: 27416551
[TBL] [Abstract] [Full Text] [Related]
13. Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.
Radford J; Illidge T; Counsell N; Hancock B; Pettengell R; Johnson P; Wimperis J; Culligan D; Popova B; Smith P; McMillan A; Brownell A; Kruger A; Lister A; Hoskin P; O'Doherty M; Barrington S
N Engl J Med; 2015 Apr; 372(17):1598-607. PubMed ID: 25901426
[TBL] [Abstract] [Full Text] [Related]
14. Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysis.
Vay A; Kumar S; Seward S; Semaan A; Schiffer CA; Munkarah AR; Morris RT
Gynecol Oncol; 2011 Dec; 123(3):456-60. PubMed ID: 21855120
[TBL] [Abstract] [Full Text] [Related]
15. Bcl-3/IgH translocation (14;19)(q32;q13) in non-Hodgkin's lymphomas.
Au WY; Horsman DE; Ohno H; Klasa RJ; Gascoyne RD
Leuk Lymphoma; 2002 Apr; 43(4):813-6. PubMed ID: 12153169
[TBL] [Abstract] [Full Text] [Related]
16. Cytogenetic abnormalities in chronic lymphocytic leukemia.
Karnolsky IN
Folia Med (Plovdiv); 2000; 42(3):5-10. PubMed ID: 11347338
[TBL] [Abstract] [Full Text] [Related]
17. Genes and chromosomes in chronic B-cell leukemia.
Crossen PE
Cancer Genet Cytogenet; 1997 Mar; 94(1):44-51. PubMed ID: 9078290
[TBL] [Abstract] [Full Text] [Related]
18. t(14;19)/bcl3 rearrangements in lymphoproliferative disorders: a review of 23 cases.
Michaux L; Dierlamm J; Wlodarska I; Bours V; Van den Berghe H; Hagemeijer A
Cancer Genet Cytogenet; 1997 Mar; 94(1):36-43. PubMed ID: 9078289
[TBL] [Abstract] [Full Text] [Related]
